Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 25, 2018
Patent Application Number
14241958
Date Filed
August 23, 2012
Patent Citations Received
Patent Primary Examiner
Patent abstract
There is provided a radiolabelled peptide-based compound for diagnostic imaging using positron emission tomography (PET). The compound may thus be used for diagnosis of malignant diseases. The compound is particularly useful for imaging of somatostatin overexpression in tumors, wherein the compound is capable of being imaged by PET when administered with a target dose in the range of 150-350 MBq, such as 150-250 MBq, preferable in the range of 191-210 MBq.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
